BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• Press Releases

  Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

  September 6, 2026

   · 

  8 min read
• Press Releases

  Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

  September 6, 2026

   · 

  5 min read
• Press Releases

  BioEdge Research Labs Expands Independent Analytical Testing Program

  September 6, 2026

   · 

  3 min read
• Press Releases

  Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference

  September 6, 2026

   · 

  1 min read
• Press Releases

  ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

  September 6, 2026

   · 

  19 min read
• Press Releases

  Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026

  September 6, 2026

   · 

  6 min read
• Press Releases

  Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call

  September 6, 2026

   · 

  4 min read
• Press Releases

  Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

  September 6, 2026

   · 

  2 min read